We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+7.77%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$5B
AUM Growth
+$283M
Cap. Flow
-$6.9M
Cap. Flow %
-0.14%
Top 10 Hldgs %
18.22%
Holding
1,507
New
129
Increased
613
Reduced
585
Closed
96

Top Buys

Rank Stock Value
1
BB icon
BlackBerry
BB
+$5.12M
2
WCC
WESCO International
WCC
+$4.99M
3
DDEC icon
FT Vest US Equity Deep Buffer ETF December
DDEC
+$4.61M
4
XOM icon
ExxonMobil
XOM
+$4.22M
5
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
+$3.55M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$9.57M
2
AAPL icon
Apple
AAPL
+$7.32M
3
ABB
ABB Ltd
ABB
+$7.11M
4
NVDA icon
NVIDIA
NVDA
+$6.77M
5
ALL icon
Allstate
ALL
+$6.29M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Financials 10.19%
3 Healthcare 9.77%
4 Industrials 9.03%
5 Consumer Discretionary 7.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
THW
1326
abrdn World Healthcare Fund
THW
$536M
$143K ﹤0.01%
+10,199
New +$144K
CIM
1327
Chimera Investment
CIM
$1.04B
$143K ﹤0.01%
8,250
– –
NVAX icon
1328
Novavax
NVAX
$1.2B
$142K ﹤0.01%
19,117
-4,550
-19% -$35.8K
GBDC icon
1329
Golub Capital BDC
GBDC
$3.34B
$142K ﹤0.01%
+10,496
New +$139K
NZF icon
1330
Nuveen Municipal Credit Income Fund
NZF
$2.4B
$138K ﹤0.01%
11,851
-900
-7% -$10.4K
CHY
1331
Calamos Convertible and High Income Fund
CHY
$1.01B
$135K ﹤0.01%
12,062
-1,119
-8% -$12K
TEVA icon
1332
Teva Pharmaceuticals
TEVA
$40.8B
$135K ﹤0.01%
17,870
-45,163
-72% -$366K
EAD
1333
Allspring Income Opportunities Fund
EAD
$372M
$130K ﹤0.01%
20,100
– –
JRI icon
1334
Nuveen Real Asset Income & Growth Fund
JRI
$356M
$128K ﹤0.01%
+11,243
New +$128K
ADT icon
1335
ADT
ADT
$5.58B
$124K ﹤0.01%
+20,634
New +$129K
SNAP icon
1336
Snap
SNAP
$7.89B
$123K ﹤0.01%
+10,429
New +$105K
JFR icon
1337
Nuveen Floating Rate Income Fund
JFR
$1.24B
$122K ﹤0.01%
+15,521
New +$125K
RIOT icon
1338
Riot Platforms
RIOT
$7.63B
$121K ﹤0.01%
10,270
-308
-3% -$3.45K
ATXS
1339
DELISTED
Astria Therapeutics
ATXS
$121K ﹤0.01%
14,527
-1,500
-9% -$17.3K
AG icon
1340
First Majestic Silver
AG
$7.41B
$120K ﹤0.01%
21,255
– –
ERIC icon
1341
Ericsson
ERIC
$32.2B
$120K ﹤0.01%
22,004
-13,166
-37% -$70.6K
MIR icon
1342
Mirion Technologies
MIR
$3.73B
$117K ﹤0.01%
+13,900
New +$113K
OSCR icon
1343
Oscar Health
OSCR
$9.41B
$117K ﹤0.01%
14,500
– –
GENI icon
1344
Genius Sports
GENI
$1.85B
$116K ﹤0.01%
18,775
+1,000
+6% +$5.02K
WIW
1345
Western Asset Inflation-Linked Opportunities & Income Fund
WIW
$505M
$116K ﹤0.01%
13,100
-8,700
-40% -$79K
NWL icon
1346
Newell Brands
NWL
$2.38B
$116K ﹤0.01%
13,317
-46,114
-78% -$459K
ELAN icon
1347
Elanco Animal Health
ELAN
$13.2B
$115K ﹤0.01%
11,398
-3,055
-21% -$28.4K
DNOW icon
1348
DNOW Inc
DNOW
$2.58B
$113K ﹤0.01%
+10,894
New +$109K
MMU
1349
Western Asset Managed Municipals Fund
MMU
$548M
$112K ﹤0.01%
11,319
-4,479
-28% -$44.9K
AEG icon
1350
Aegon
AEG
$14B
$111K ﹤0.01%
21,984
– –
52 53
54
55 56

Similar funds

LGF
LGT Group Foundation Vaduz, Liechtenstein $8.19B AUM 27.7% 1-Year Est. Return
CCM
Causeway Capital Management Los Angeles, California $8.15B AUM 29.28% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $8.15B AUM 20.12% 1-Year Est. Return
WJWM
Williams Jones Wealth Management New York $8.14B AUM 19.32% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return
AIM
Allen Investment Management New York $8.09B AUM 16.78% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Oppenheimer & Co's Q2 2023 Portfolio in Review

As of Q2 2023, Oppenheimer & Co held 1,507 positions worth $5B, up 6% from $4.72B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Oppenheimer & Co's Q2 2023 filing shows 129 new, 613 increased, 585 reduced and 96 closed positions. Its largest new stake was Ovintiv: 88,415 shares worth $3.37M. The largest sale was Microsoft, an estimated $9.57M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Oppenheimer & Co's largest Q2 2023 buy was Ovintiv: 88,415 shares worth $3.37M.
  • Oppenheimer & Co added most to BlackBerry in Q2 2023, an estimated $5.12M increase.
  • Oppenheimer & Co's biggest Q2 2023 reduction was Microsoft, cutting an estimated $9.57M.
  • Oppenheimer & Co fully exited ABB Ltd in Q2 2023, selling an estimated $7.11M.
  • Oppenheimer & Co's ten largest holdings make up 18% of its $5B portfolio in Q2 2023.
  • Oppenheimer & Co opened 129 new positions and closed 96 in Q2 2023.
  • Oppenheimer & Co's portfolio value rose 6% quarter-over-quarter to $5B.

Based on Oppenheimer & Co's 13F filing for Q2 2023, filed 3 Aug 2023.